microRNA information: hsa-miR-340-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-340-5p | miRbase |
| Accession: | MIMAT0004692 | miRbase |
| Precursor name: | hsa-mir-340 | miRbase |
| Precursor accession: | MI0000802 | miRbase |
| Symbol: | MIR340 | HGNC |
| RefSeq ID: | NR_029885 | GenBank |
| Sequence: | UUAUAAAGCAAUGAGACUGAUU |
Reported expression in cancers: hsa-miR-340-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-340-5p | breast cancer | downregulation | "They then analyzed miR-340 expression in benign an ......" | 21692045 | qPCR |
| hsa-miR-340-5p | esophageal cancer | downregulation | "Emerging evidence indicates that microRNA miR-340 ......" | 26316084 | qPCR |
| hsa-miR-340-5p | gastric cancer | upregulation | "However the clinical significance and underlying m ......" | 27374211 | |
| hsa-miR-340-5p | glioblastoma | downregulation | "miRNA microarray reveals specific expression in th ......" | 24858071 | Microarray |
| hsa-miR-340-5p | glioblastoma | downregulation | "Here we provide evidence for a function of miR-340 ......" | 25817794 | |
| hsa-miR-340-5p | glioblastoma | downregulation | "miR 340 suppresses glioblastoma multiforme. Down-r ......" | 25831237 | |
| hsa-miR-340-5p | lung squamous cell cancer | downregulation | "miR 340 inhibits tumor cell proliferation and indu ......" | 25151966 | |
| hsa-miR-340-5p | ovarian cancer | upregulation | "Aberrant expression of microRNA-340 miR-340 has be ......" | 27160777 | |
| hsa-miR-340-5p | prostate cancer | downregulation | "microRNA-340 miR-340 has been reported as a tumor ......" | 26394192 | |
| hsa-miR-340-5p | prostate cancer | downregulation | "In the present study we found that miR-340 may act ......" | 26718483 | |
| hsa-miR-340-5p | sarcoma | downregulation | "Our results showed that miR-340 was frequently dow ......" | 23872151 |
Reported cancer pathway affected by hsa-miR-340-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-340-5p | breast cancer | Wnt signaling pathway | "MicroRNA 340 inhibits the migration invasion and m ......" | 26758430 | Western blot; Luciferase |
| hsa-miR-340-5p | breast cancer | cell cycle pathway | "The effect of miR 340 over expression on cell cycl ......" | 27229858 | |
| hsa-miR-340-5p | gastric cancer | Apoptosis pathway; cell cycle pathway | "Effect of miR 340 on gastric cancer cell prolifera ......" | 26722508 | Colony formation; Flow cytometry |
| hsa-miR-340-5p | gastric cancer | cell cycle pathway | "MicroRNA 340 promotes the tumor growth of human ga ......" | 27374211 | Colony formation; Luciferase |
| hsa-miR-340-5p | glioblastoma | cell cycle pathway | "miR 340 inhibits glioblastoma cell proliferation b ......" | 25817794 | Western blot; Luciferase |
| hsa-miR-340-5p | glioblastoma | cell cycle pathway; Apoptosis pathway | "miR 340 suppresses glioblastoma multiforme; Down-r ......" | 25831237 | |
| hsa-miR-340-5p | lung squamous cell cancer | Apoptosis pathway | "miR 340 inhibits tumor cell proliferation and indu ......" | 25151966 | |
| hsa-miR-340-5p | melanoma | MAPK signaling pathway | "MicroRNA 340 as a modulator of RAS RAF MAPK signal ......" | 25043973 | |
| hsa-miR-340-5p | ovarian cancer | Apoptosis pathway; cell cycle pathway | "MicroRNA 340 Induces Apoptosis and Inhibits Metast ......" | 27160777 | Flow cytometry; Western blot; Luciferase |
Reported cancer prognosis affected by hsa-miR-340-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-340-5p | breast cancer | cell migration; staging; metastasis; poor survival; progression; worse prognosis | "miR 340 inhibition of breast cancer cell migration ......" | 21692045 | |
| hsa-miR-340-5p | breast cancer | cell migration | "MiR 340 suppresses cell migration and invasion by ......" | 26573744 | Wound Healing Assay |
| hsa-miR-340-5p | breast cancer | metastasis | "MicroRNA 340 inhibits the migration invasion and m ......" | 26758430 | Western blot; Luciferase |
| hsa-miR-340-5p | breast cancer | progression | "miR 340 and ZEB1 negative feedback loop regulates ......" | 27036021 | |
| hsa-miR-340-5p | breast cancer | metastasis | "The effect of miR 340 over expression on cell cycl ......" | 27229858 | |
| hsa-miR-340-5p | colorectal cancer | worse prognosis | "miR 124 miR 137 and miR 340 regulate colorectal ca ......" | 22895557 | |
| hsa-miR-340-5p | colorectal cancer | metastasis; poor survival; worse prognosis | "Decreased miR 340 expression in bone marrow is ass ......" | 24448820 | |
| hsa-miR-340-5p | esophageal cancer | metastasis; progression | "MicroRNA 340 Inhibits Esophageal Cancer Cell Growt ......" | 26316084 | Western blot; Luciferase; Colony formation |
| hsa-miR-340-5p | gastric cancer | staging; metastasis; differentiation; tumor size; poor survival; progression | "MicroRNA 340 promotes the tumor growth of human ga ......" | 27374211 | Colony formation; Luciferase |
| hsa-miR-340-5p | glioblastoma | poor survival; differentiation; motility; worse prognosis | "miR 340 suppresses glioblastoma multiforme; Down-r ......" | 25831237 | |
| hsa-miR-340-5p | glioblastoma | poor survival; worse prognosis; tumorigenesis | "miR 340 predicts glioblastoma survival and modulat ......" | 26799668 | |
| hsa-miR-340-5p | glioblastoma | malignant trasformation | "Combined with high throughput sequencing analysis ......" | 27614160 | |
| hsa-miR-340-5p | liver cancer | drug resistance | "miR 340 reverses cisplatin resistance of hepatocel ......" | 25556489 | Luciferase |
| hsa-miR-340-5p | lung squamous cell cancer | motility; staging; progression | "miR 340 inhibits tumor cell proliferation and indu ......" | 25151966 | |
| hsa-miR-340-5p | melanoma | drug resistance | "Diminution of miR 340 5p levels is responsible for ......" | 26554847 | |
| hsa-miR-340-5p | ovarian cancer | drug resistance | "Of these 10 miRNAs miR-193a-5p miR-375 miR-339-3p ......" | 26485143 | |
| hsa-miR-340-5p | ovarian cancer | metastasis; progression | "MicroRNA 340 Induces Apoptosis and Inhibits Metast ......" | 27160777 | Flow cytometry; Western blot; Luciferase |
| hsa-miR-340-5p | prostate cancer | progression | "microRNA 340 Suppresses Tumorigenic Potential of P ......" | 26394192 | Luciferase; Western blot |
| hsa-miR-340-5p | prostate cancer | metastasis | "MicroRNA 340 inhibits prostate cancer cell prolife ......" | 26718483 | |
| hsa-miR-340-5p | sarcoma | metastasis; progression | "MicroRNA 340 suppresses osteosarcoma tumor growth ......" | 23872151 | |
| hsa-miR-340-5p | sarcoma | progression; worse prognosis; metastasis; drug resistance | "Combined microRNA 340 and ROCK1 mRNA profiling pre ......" | 24398981 |
Reported gene related to hsa-miR-340-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-340-5p | glioblastoma | ROCK1 | "Furthermore ROCK1 was validated as a direct functi ......" | 25831237 |
| hsa-miR-340-5p | sarcoma | ROCK1 | "MicroRNA 340 suppresses osteosarcoma tumor growth ......" | 23872151 |
| hsa-miR-340-5p | sarcoma | ROCK1 | "Combined microRNA 340 and ROCK1 mRNA profiling pre ......" | 24398981 |
| hsa-miR-340-5p | breast cancer | MET | "miR 340 inhibition of breast cancer cell migration ......" | 21692045 |
| hsa-miR-340-5p | colorectal cancer | MET | "It was of note that the colorectal cancer group wi ......" | 24448820 |
| hsa-miR-340-5p | melanoma | ABCB5 | "Diminution of miR 340 5p levels is responsible for ......" | 26554847 |
| hsa-miR-340-5p | gastric cancer | CCNG2 | "MicroRNA 340 promotes the tumor growth of human ga ......" | 27374211 |
| hsa-miR-340-5p | lung cancer | CDKN1B | "A novel miRNA mediated STOP sign in lung cancer: m ......" | 27308439 |
| hsa-miR-340-5p | lung cancer | CDKN3 | "miR-340 inhibits neoplastic cell proliferation and ......" | 27308439 |
| hsa-miR-340-5p | prostate cancer | HMGN5 | "Intriguingly on the basis of bioinformatics analys ......" | 26394192 |
| hsa-miR-340-5p | lung cancer | MAP6 | "A novel miRNA mediated STOP sign in lung cancer: m ......" | 27308439 |
| hsa-miR-340-5p | prostate cancer | MDM2 | "MicroRNA 340 inhibits prostate cancer cell prolife ......" | 26718483 |
| hsa-miR-340-5p | breast cancer | MYO10 | "MiR 340 suppresses cell migration and invasion by ......" | 26573744 |
| hsa-miR-340-5p | ovarian cancer | NFASC | "MicroRNA 340 Induces Apoptosis and Inhibits Metast ......" | 27160777 |
| hsa-miR-340-5p | glioblastoma | NRAS | "miR 340 predicts glioblastoma survival and modulat ......" | 26799668 |
| hsa-miR-340-5p | glioblastoma | NT5E | "Three miRNAs miR-340 -494 and -1293 active on cell ......" | 27614160 |
| hsa-miR-340-5p | gastric cancer | PCNA | "MicroRNA 340 promotes the tumor growth of human ga ......" | 27374211 |
| hsa-miR-340-5p | esophageal cancer | PSAT1 | "MicroRNA 340 Inhibits Esophageal Cancer Cell Growt ......" | 26316084 |
| hsa-miR-340-5p | lung squamous cell cancer | PUM1 | "Accordingly the inhibition of either PUM1 or SKP2 ......" | 25151966 |
| hsa-miR-340-5p | lung squamous cell cancer | SKP2 | "At the same time miR-340 induces the stabilization ......" | 25151966 |
| hsa-miR-340-5p | prostate cancer | TP53 | "MicroRNA 340 inhibits prostate cancer cell prolife ......" | 26718483 |
| hsa-miR-340-5p | breast cancer | ZEB1 | "miR 340 and ZEB1 negative feedback loop regulates ......" | 27036021 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-340-5p | ID4 | 9 cancers: BLCA; BRCA; KIRP; LGG; LIHC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.261; TCGA BRCA -0.248; TCGA KIRP -0.242; TCGA LGG -0.115; TCGA LIHC -0.218; TCGA PRAD -0.291; TCGA SARC -0.39; TCGA STAD -0.216; TCGA UCEC -0.17 |
hsa-miR-340-5p | LMNA | 9 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.154; TCGA CESC -0.105; TCGA ESCA -0.145; TCGA HNSC -0.109; TCGA LUAD -0.106; TCGA LUSC -0.183; TCGA PRAD -0.159; TCGA STAD -0.122; TCGA UCEC -0.204 |
hsa-miR-340-5p | RNF11 | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.089; TCGA BRCA -0.142; TCGA HNSC -0.152; TCGA KIRC -0.099; TCGA KIRP -0.133; TCGA PAAD -0.086; TCGA SARC -0.129; TCGA STAD -0.183; TCGA UCEC -0.107 |
hsa-miR-340-5p | SYPL1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.146; TCGA BRCA -0.117; TCGA ESCA -0.175; TCGA HNSC -0.082; TCGA KIRC -0.08; TCGA PAAD -0.152; TCGA SARC -0.231; TCGA STAD -0.112; TCGA UCEC -0.128 |
hsa-miR-340-5p | UBL3 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.17; TCGA BRCA -0.215; TCGA COAD -0.111; TCGA KIRC -0.219; TCGA KIRP -0.13; TCGA LGG -0.058; TCGA LUSC -0.168; TCGA PAAD -0.101; TCGA STAD -0.153; TCGA UCEC -0.221 |
hsa-miR-340-5p | DYNC1I2 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; PAAD; SARC; UCEC | MirTarget | TCGA BLCA -0.067; TCGA BRCA -0.144; TCGA CESC -0.068; TCGA HNSC -0.115; TCGA KIRC -0.052; TCGA KIRP -0.098; TCGA PAAD -0.15; TCGA SARC -0.103; TCGA UCEC -0.094 |
hsa-miR-340-5p | LAPTM4A | 10 cancers: BLCA; CESC; HNSC; LGG; LIHC; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.061; TCGA CESC -0.083; TCGA HNSC -0.079; TCGA LGG -0.067; TCGA LIHC -0.103; TCGA PAAD -0.107; TCGA PRAD -0.07; TCGA THCA -0.052; TCGA STAD -0.11; TCGA UCEC -0.115 |
hsa-miR-340-5p | EDA2R | 9 cancers: BLCA; BRCA; COAD; LIHC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.357; TCGA BRCA -0.363; TCGA COAD -0.313; TCGA LIHC -0.299; TCGA LUSC -0.188; TCGA PRAD -0.179; TCGA SARC -0.435; TCGA STAD -0.21; TCGA UCEC -0.525 |
hsa-miR-340-5p | CASC4 | 9 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LGG; PAAD; SARC; UCEC | MirTarget | TCGA BLCA -0.089; TCGA BRCA -0.185; TCGA CESC -0.106; TCGA ESCA -0.115; TCGA KIRP -0.097; TCGA LGG -0.068; TCGA PAAD -0.114; TCGA SARC -0.086; TCGA UCEC -0.142 |
hsa-miR-340-5p | SYTL4 | 11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.318; TCGA BRCA -0.228; TCGA CESC -0.253; TCGA KIRC -0.284; TCGA KIRP -0.371; TCGA LGG -0.219; TCGA LUAD -0.086; TCGA PAAD -0.349; TCGA PRAD -0.145; TCGA STAD -0.18; TCGA UCEC -0.375 |
hsa-miR-340-5p | PBX1 | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.175; TCGA BRCA -0.157; TCGA COAD -0.195; TCGA KIRC -0.418; TCGA KIRP -0.295; TCGA LGG -0.105; TCGA PAAD -0.136; TCGA PRAD -0.166; TCGA SARC -0.677; TCGA STAD -0.362; TCGA UCEC -0.149 |
hsa-miR-340-5p | NFAT5 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; PAAD; SARC; UCEC | MirTarget | TCGA BLCA -0.151; TCGA BRCA -0.253; TCGA ESCA -0.141; TCGA HNSC -0.088; TCGA KIRC -0.178; TCGA KIRP -0.281; TCGA PAAD -0.125; TCGA SARC -0.098; TCGA UCEC -0.178 |
hsa-miR-340-5p | HERC3 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.131; TCGA BRCA -0.198; TCGA ESCA -0.228; TCGA HNSC -0.167; TCGA KIRP -0.131; TCGA PAAD -0.172; TCGA SARC -0.161; TCGA STAD -0.136; TCGA UCEC -0.266 |
hsa-miR-340-5p | SLK | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.124; TCGA BRCA -0.216; TCGA ESCA -0.19; TCGA HNSC -0.125; TCGA KIRC -0.088; TCGA KIRP -0.248; TCGA LUSC -0.171; TCGA PAAD -0.214; TCGA SARC -0.088; TCGA STAD -0.158; TCGA UCEC -0.192 |
hsa-miR-340-5p | TBC1D8B | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; PAAD; UCEC | MirTarget | TCGA BLCA -0.123; TCGA BRCA -0.226; TCGA CESC -0.186; TCGA COAD -0.125; TCGA ESCA -0.263; TCGA KIRP -0.157; TCGA LUAD -0.086; TCGA LUSC -0.161; TCGA PAAD -0.354; TCGA UCEC -0.187 |
hsa-miR-340-5p | FRMD6 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.261; TCGA BRCA -0.294; TCGA COAD -0.246; TCGA HNSC -0.151; TCGA KIRP -0.28; TCGA LUSC -0.275; TCGA PAAD -0.511; TCGA PRAD -0.324; TCGA SARC -0.378; TCGA STAD -0.255; TCGA UCEC -0.457 |
hsa-miR-340-5p | MTMR10 | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.107; TCGA BRCA -0.228; TCGA CESC -0.082; TCGA KIRC -0.23; TCGA KIRP -0.094; TCGA LUSC -0.086; TCGA PRAD -0.066; TCGA STAD -0.125; TCGA UCEC -0.115 |
hsa-miR-340-5p | VCL | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.105; TCGA BRCA -0.235; TCGA CESC -0.101; TCGA COAD -0.135; TCGA KIRC -0.146; TCGA KIRP -0.334; TCGA LUSC -0.207; TCGA PAAD -0.202; TCGA PRAD -0.277; TCGA SARC -0.521; TCGA STAD -0.35; TCGA UCEC -0.317 |
hsa-miR-340-5p | ARHGAP6 | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.505; TCGA BRCA -0.206; TCGA COAD -0.595; TCGA KIRC -0.181; TCGA KIRP -0.14; TCGA PAAD -0.202; TCGA SARC -0.291; TCGA STAD -0.369; TCGA UCEC -0.571 |
hsa-miR-340-5p | ATP2B4 | 10 cancers: BLCA; BRCA; COAD; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.19; TCGA BRCA -0.231; TCGA COAD -0.252; TCGA KIRP -0.115; TCGA LUSC -0.207; TCGA PAAD -0.15; TCGA PRAD -0.397; TCGA SARC -0.554; TCGA STAD -0.496; TCGA UCEC -0.115 |
hsa-miR-340-5p | TGFBR3 | 9 cancers: BLCA; BRCA; KIRC; KIRP; LGG; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.3; TCGA BRCA -0.424; TCGA KIRC -0.205; TCGA KIRP -0.248; TCGA LGG -0.096; TCGA PRAD -0.228; TCGA SARC -0.232; TCGA STAD -0.347; TCGA UCEC -0.35 |
hsa-miR-340-5p | XIAP | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.087; TCGA BRCA -0.127; TCGA COAD -0.09; TCGA ESCA -0.153; TCGA KIRC -0.084; TCGA KIRP -0.171; TCGA LGG -0.058; TCGA LUSC -0.09; TCGA PAAD -0.091; TCGA UCEC -0.052 |
hsa-miR-340-5p | LONP2 | 9 cancers: BLCA; BRCA; ESCA; KIRC; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.108; TCGA BRCA -0.173; TCGA ESCA -0.144; TCGA KIRC -0.094; TCGA LUSC -0.132; TCGA PAAD -0.193; TCGA SARC -0.092; TCGA STAD -0.131; TCGA UCEC -0.113 |
hsa-miR-340-5p | TTC23 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.168; TCGA BRCA -0.144; TCGA CESC -0.114; TCGA ESCA -0.147; TCGA HNSC -0.086; TCGA KIRC -0.065; TCGA KIRP -0.06; TCGA PAAD -0.137; TCGA STAD -0.213; TCGA UCEC -0.083 |
hsa-miR-340-5p | KANK1 | 9 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUSC; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.195; TCGA BRCA -0.268; TCGA HNSC -0.194; TCGA KIRC -0.09; TCGA LGG -0.1; TCGA LUSC -0.135; TCGA PRAD -0.107; TCGA SARC -0.692; TCGA UCEC -0.266 |
hsa-miR-340-5p | INPP4B | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.419; TCGA BRCA -0.345; TCGA CESC -0.509; TCGA COAD -0.166; TCGA ESCA -0.432; TCGA HNSC -0.266; TCGA KIRP -0.27; TCGA LUAD -0.172; TCGA LUSC -0.437; TCGA PAAD -0.353; TCGA STAD -0.276; TCGA UCEC -0.321 |
hsa-miR-340-5p | RNF141 | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; STAD | mirMAP | TCGA BLCA -0.092; TCGA BRCA -0.177; TCGA HNSC -0.123; TCGA KIRC -0.128; TCGA KIRP -0.082; TCGA LGG -0.056; TCGA LUSC -0.186; TCGA PAAD -0.173; TCGA STAD -0.117 |
hsa-miR-340-5p | FOXP1 | 10 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.148; TCGA BRCA -0.131; TCGA CESC -0.174; TCGA KIRC -0.168; TCGA KIRP -0.181; TCGA LUSC -0.197; TCGA PAAD -0.125; TCGA SARC -0.17; TCGA STAD -0.208; TCGA UCEC -0.144 |
hsa-miR-340-5p | FHL2 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.317; TCGA BRCA -0.182; TCGA CESC -0.474; TCGA ESCA -0.207; TCGA HNSC -0.176; TCGA KIRP -0.188; TCGA LIHC -0.253; TCGA LUAD -0.136; TCGA LUSC -0.404; TCGA PAAD -0.245; TCGA PRAD -0.34; TCGA SARC -0.505; TCGA STAD -0.43; TCGA UCEC -0.273 |
hsa-miR-340-5p | LEPR | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.175; TCGA BRCA -0.402; TCGA CESC -0.179; TCGA KIRC -0.104; TCGA KIRP -0.151; TCGA PAAD -0.227; TCGA PRAD -0.158; TCGA STAD -0.286; TCGA UCEC -0.547 |
hsa-miR-340-5p | FLRT3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; UCEC | mirMAP | TCGA BLCA -0.273; TCGA BRCA -0.464; TCGA CESC -0.674; TCGA ESCA -0.704; TCGA HNSC -0.545; TCGA KIRC -0.192; TCGA KIRP -0.277; TCGA LUSC -0.387; TCGA PAAD -0.475; TCGA PRAD -0.365; TCGA UCEC -0.276 |
hsa-miR-340-5p | CASZ1 | 9 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LUAD; LUSC; SARC; STAD | mirMAP | TCGA BLCA -0.114; TCGA BRCA -0.08; TCGA ESCA -0.224; TCGA KIRC -0.476; TCGA KIRP -0.39; TCGA LUAD -0.087; TCGA LUSC -0.158; TCGA SARC -0.509; TCGA STAD -0.319 |
hsa-miR-340-5p | MEIS2 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.271; TCGA BRCA -0.186; TCGA CESC -0.233; TCGA COAD -0.383; TCGA ESCA -0.17; TCGA KIRC -0.19; TCGA PRAD -0.423; TCGA SARC -0.65; TCGA STAD -0.417 |
hsa-miR-340-5p | PHLDB2 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.265; TCGA BRCA -0.369; TCGA COAD -0.338; TCGA HNSC -0.239; TCGA KIRC -0.089; TCGA KIRP -0.184; TCGA LUSC -0.399; TCGA SARC -0.478; TCGA STAD -0.265; TCGA UCEC -0.655 |
hsa-miR-340-5p | TMEM47 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.332; TCGA BRCA -0.329; TCGA CESC -0.368; TCGA COAD -0.238; TCGA KIRP -0.389; TCGA LGG -0.107; TCGA LUSC -0.199; TCGA PAAD -0.261; TCGA PRAD -0.143; TCGA SARC -0.656; TCGA STAD -0.267; TCGA UCEC -0.245 |
hsa-miR-340-5p | PLA2R1 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.136; TCGA BRCA -0.476; TCGA COAD -0.366; TCGA ESCA -0.245; TCGA KIRC -0.569; TCGA KIRP -0.233; TCGA LUSC -0.277; TCGA PAAD -0.526; TCGA PRAD -0.155; TCGA SARC -0.284; TCGA UCEC -0.216 |
hsa-miR-340-5p | PRKCA | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.17; TCGA BRCA -0.158; TCGA CESC -0.248; TCGA COAD -0.128; TCGA ESCA -0.302; TCGA KIRC -0.258; TCGA KIRP -0.223; TCGA LUSC -0.264; TCGA PAAD -0.225; TCGA STAD -0.307; TCGA UCEC -0.45 |
hsa-miR-340-5p | ETS2 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUSC; PRAD; SARC; UCEC | mirMAP | TCGA BLCA -0.21; TCGA BRCA -0.064; TCGA CESC -0.161; TCGA ESCA -0.212; TCGA HNSC -0.089; TCGA KIRP -0.171; TCGA LUSC -0.156; TCGA PRAD -0.253; TCGA SARC -0.24; TCGA UCEC -0.099 |
hsa-miR-340-5p | ANTXR2 | 12 cancers: BLCA; BRCA; CESC; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.195; TCGA BRCA -0.258; TCGA CESC -0.295; TCGA ESCA -0.308; TCGA LIHC -0.162; TCGA LUAD -0.072; TCGA LUSC -0.249; TCGA PAAD -0.388; TCGA PRAD -0.114; TCGA SARC -0.188; TCGA STAD -0.433; TCGA UCEC -0.528 |
hsa-miR-340-5p | C16orf45 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.266; TCGA BRCA -0.219; TCGA COAD -0.239; TCGA KIRC -0.176; TCGA KIRP -0.221; TCGA LUAD -0.17; TCGA PRAD -0.294; TCGA SARC -0.34; TCGA STAD -0.311; TCGA UCEC -0.5 |
hsa-miR-340-5p | TMEM133 | 9 cancers: BLCA; BRCA; CESC; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.111; TCGA BRCA -0.206; TCGA CESC -0.368; TCGA LGG -0.119; TCGA LUSC -0.154; TCGA PAAD -0.235; TCGA SARC -0.365; TCGA STAD -0.162; TCGA UCEC -0.25 |
hsa-miR-340-5p | TMEM43 | 9 cancers: BLCA; BRCA; CESC; COAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.067; TCGA BRCA -0.155; TCGA CESC -0.083; TCGA COAD -0.06; TCGA LUSC -0.108; TCGA PAAD -0.166; TCGA SARC -0.164; TCGA STAD -0.2; TCGA UCEC -0.268 |
hsa-miR-340-5p | ANO6 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.112; TCGA BRCA -0.324; TCGA CESC -0.091; TCGA COAD -0.179; TCGA ESCA -0.237; TCGA KIRP -0.129; TCGA LUSC -0.215; TCGA PAAD -0.399; TCGA PRAD -0.209; TCGA SARC -0.177; TCGA STAD -0.207; TCGA UCEC -0.309 |
hsa-miR-340-5p | CHD9 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.14; TCGA BRCA -0.337; TCGA COAD -0.114; TCGA ESCA -0.117; TCGA KIRP -0.2; TCGA LGG -0.131; TCGA LUSC -0.122; TCGA PAAD -0.138; TCGA STAD -0.129; TCGA UCEC -0.231 |
hsa-miR-340-5p | ZFP36L1 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.105; TCGA CESC -0.183; TCGA ESCA -0.201; TCGA HNSC -0.073; TCGA KIRP -0.134; TCGA LGG -0.084; TCGA PAAD -0.297; TCGA SARC -0.086; TCGA STAD -0.172; TCGA UCEC -0.154 |
hsa-miR-340-5p | THSD4 | 10 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.168; TCGA BRCA -0.47; TCGA KIRC -0.536; TCGA KIRP -0.534; TCGA LGG -0.205; TCGA LUSC -0.342; TCGA PAAD -0.345; TCGA PRAD -0.244; TCGA SARC -0.788; TCGA STAD -0.403 |
hsa-miR-340-5p | NBR1 | 9 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.095; TCGA BRCA -0.217; TCGA ESCA -0.158; TCGA KIRC -0.06; TCGA KIRP -0.058; TCGA PAAD -0.084; TCGA SARC -0.115; TCGA STAD -0.119; TCGA UCEC -0.179 |
hsa-miR-340-5p | CAST | 9 cancers: BLCA; BRCA; ESCA; HNSC; LUSC; PAAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.172; TCGA BRCA -0.157; TCGA ESCA -0.138; TCGA HNSC -0.084; TCGA LUSC -0.125; TCGA PAAD -0.198; TCGA SARC -0.117; TCGA STAD -0.176; TCGA UCEC -0.125 |
hsa-miR-340-5p | MYO1C | 13 cancers: BLCA; BRCA; CESC; ESCA; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.154; TCGA BRCA -0.145; TCGA CESC -0.179; TCGA ESCA -0.121; TCGA KIRP -0.072; TCGA LIHC -0.093; TCGA LUAD -0.069; TCGA LUSC -0.202; TCGA PAAD -0.128; TCGA PRAD -0.137; TCGA SARC -0.202; TCGA STAD -0.212; TCGA UCEC -0.205 |
hsa-miR-340-5p | CRY2 | 10 cancers: BRCA; CESC; COAD; KIRC; KIRP; LGG; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.203; TCGA CESC -0.072; TCGA COAD -0.08; TCGA KIRC -0.121; TCGA KIRP -0.104; TCGA LGG -0.103; TCGA PRAD -0.112; TCGA SARC -0.131; TCGA STAD -0.16; TCGA UCEC -0.171 |
hsa-miR-340-5p | FBXL3 | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.236; TCGA COAD -0.101; TCGA ESCA -0.095; TCGA KIRC -0.093; TCGA KIRP -0.166; TCGA LUSC -0.132; TCGA PAAD -0.097; TCGA SARC -0.159; TCGA STAD -0.091; TCGA UCEC -0.234 |
hsa-miR-340-5p | GK5 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; PAAD; SARC; THCA; STAD | miRNAWalker2 validate; MirTarget | TCGA BRCA -0.101; TCGA ESCA -0.158; TCGA KIRC -0.167; TCGA KIRP -0.142; TCGA LGG -0.062; TCGA PAAD -0.111; TCGA SARC -0.301; TCGA THCA -0.074; TCGA STAD -0.141 |
hsa-miR-340-5p | ITPR1 | 9 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.488; TCGA COAD -0.34; TCGA KIRC -0.299; TCGA KIRP -0.433; TCGA LUSC -0.184; TCGA PRAD -0.426; TCGA SARC -0.785; TCGA STAD -0.18; TCGA UCEC -0.444 |
hsa-miR-340-5p | KLF10 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.25; TCGA CESC -0.101; TCGA ESCA -0.28; TCGA HNSC -0.171; TCGA KIRP -0.153; TCGA LGG -0.125; TCGA LUSC -0.277; TCGA PAAD -0.145; TCGA SARC -0.115; TCGA STAD -0.266; TCGA UCEC -0.194 |
hsa-miR-340-5p | LEPROT | 9 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BRCA -0.392; TCGA COAD -0.124; TCGA KIRC -0.183; TCGA KIRP -0.259; TCGA LUSC -0.219; TCGA PAAD -0.343; TCGA SARC -0.178; TCGA STAD -0.128; TCGA UCEC -0.453 |
hsa-miR-340-5p | NEK7 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BRCA -0.181; TCGA CESC -0.109; TCGA ESCA -0.101; TCGA HNSC -0.186; TCGA KIRP -0.108; TCGA LUSC -0.165; TCGA PAAD -0.136; TCGA SARC -0.226; TCGA STAD -0.126; TCGA UCEC -0.129 |
hsa-miR-340-5p | CEP68 | 9 cancers: BRCA; KIRC; KIRP; LGG; LIHC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.209; TCGA KIRC -0.06; TCGA KIRP -0.146; TCGA LGG -0.056; TCGA LIHC -0.07; TCGA PRAD -0.099; TCGA SARC -0.214; TCGA STAD -0.152; TCGA UCEC -0.137 |
hsa-miR-340-5p | ZCCHC14 | 9 cancers: BRCA; COAD; KIRC; KIRP; LGG; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BRCA -0.104; TCGA COAD -0.127; TCGA KIRC -0.081; TCGA KIRP -0.2; TCGA LGG -0.072; TCGA LUSC -0.134; TCGA PAAD -0.104; TCGA STAD -0.108; TCGA UCEC -0.22 |
hsa-miR-340-5p | MSRB3 | 10 cancers: BRCA; CESC; COAD; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BRCA -0.382; TCGA CESC -0.201; TCGA COAD -0.435; TCGA KIRP -0.258; TCGA LUSC -0.253; TCGA PAAD -0.353; TCGA PRAD -0.437; TCGA SARC -0.748; TCGA STAD -0.472; TCGA UCEC -0.672 |
hsa-miR-340-5p | SEC23A | 9 cancers: BRCA; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.169; TCGA ESCA -0.215; TCGA HNSC -0.102; TCGA LUSC -0.15; TCGA PAAD -0.243; TCGA PRAD -0.123; TCGA SARC -0.194; TCGA STAD -0.218; TCGA UCEC -0.107 |
hsa-miR-340-5p | TSC22D2 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.132; TCGA ESCA -0.199; TCGA HNSC -0.212; TCGA KIRC -0.077; TCGA KIRP -0.194; TCGA PAAD -0.188; TCGA SARC -0.168; TCGA STAD -0.158; TCGA UCEC -0.167 |
hsa-miR-340-5p | USP38 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; SARC; UCEC | MirTarget | TCGA BRCA -0.109; TCGA ESCA -0.094; TCGA KIRC -0.091; TCGA KIRP -0.103; TCGA LGG -0.082; TCGA LUSC -0.093; TCGA PAAD -0.129; TCGA SARC -0.069; TCGA UCEC -0.087 |
hsa-miR-340-5p | MYLK | 9 cancers: BRCA; COAD; KIRC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BRCA -0.424; TCGA COAD -0.506; TCGA KIRC -0.104; TCGA LUSC -0.258; TCGA PAAD -0.41; TCGA PRAD -0.568; TCGA SARC -1.62; TCGA STAD -0.68; TCGA UCEC -0.715 |
hsa-miR-340-5p | CAV1 | 9 cancers: BRCA; CESC; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.383; TCGA CESC -0.291; TCGA HNSC -0.366; TCGA LUSC -0.414; TCGA PAAD -0.302; TCGA PRAD -0.388; TCGA SARC -0.403; TCGA STAD -0.378; TCGA UCEC -0.542 |
hsa-miR-340-5p | TNS1 | 9 cancers: BRCA; COAD; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.409; TCGA COAD -0.431; TCGA KIRP -0.141; TCGA LUSC -0.204; TCGA PAAD -0.269; TCGA PRAD -0.449; TCGA SARC -0.748; TCGA STAD -0.591; TCGA UCEC -0.517 |
hsa-miR-340-5p | ITGAV | 10 cancers: BRCA; CESC; ESCA; KIRP; LGG; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.201; TCGA CESC -0.135; TCGA ESCA -0.168; TCGA KIRP -0.141; TCGA LGG -0.063; TCGA LUSC -0.233; TCGA PAAD -0.324; TCGA SARC -0.199; TCGA STAD -0.169; TCGA UCEC -0.245 |
hsa-miR-340-5p | NAA30 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; SARC; STAD | MirTarget; mirMAP | TCGA BRCA -0.154; TCGA ESCA -0.153; TCGA HNSC -0.1; TCGA KIRC -0.144; TCGA KIRP -0.097; TCGA LGG -0.059; TCGA LUSC -0.114; TCGA PAAD -0.09; TCGA SARC -0.112; TCGA STAD -0.076 |
hsa-miR-340-5p | TSPAN2 | 9 cancers: BRCA; CESC; COAD; KIRC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.142; TCGA CESC -0.433; TCGA COAD -0.279; TCGA KIRC -0.253; TCGA LUSC -0.283; TCGA PRAD -0.369; TCGA SARC -1.092; TCGA STAD -0.366; TCGA UCEC -0.509 |
hsa-miR-340-5p | PLAT | 9 cancers: BRCA; KIRC; KIRP; LIHC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.373; TCGA KIRC -0.351; TCGA KIRP -0.53; TCGA LIHC -0.186; TCGA LUSC -0.442; TCGA PAAD -0.357; TCGA SARC -0.208; TCGA STAD -0.175; TCGA UCEC -0.544 |
hsa-miR-340-5p | RALBP1 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.11; TCGA ESCA -0.147; TCGA HNSC -0.155; TCGA KIRC -0.258; TCGA KIRP -0.224; TCGA LUSC -0.074; TCGA PAAD -0.123; TCGA SARC -0.1; TCGA UCEC -0.131 |
hsa-miR-340-5p | WNK1 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.158; TCGA ESCA -0.14; TCGA KIRC -0.283; TCGA KIRP -0.249; TCGA LUSC -0.162; TCGA PAAD -0.149; TCGA SARC -0.099; TCGA STAD -0.108; TCGA UCEC -0.089 |
hsa-miR-340-5p | SNX13 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.167; TCGA ESCA -0.182; TCGA HNSC -0.055; TCGA KIRC -0.083; TCGA KIRP -0.096; TCGA LGG -0.091; TCGA LUSC -0.084; TCGA PAAD -0.115; TCGA SARC -0.063; TCGA UCEC -0.076 |
hsa-miR-340-5p | FOSL2 | 11 cancers: BRCA; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.132; TCGA ESCA -0.191; TCGA KIRC -0.125; TCGA KIRP -0.319; TCGA LUAD -0.125; TCGA LUSC -0.157; TCGA PAAD -0.351; TCGA PRAD -0.175; TCGA SARC -0.109; TCGA STAD -0.121; TCGA UCEC -0.242 |
hsa-miR-340-5p | GSK3B | 9 cancers: BRCA; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BRCA -0.12; TCGA ESCA -0.185; TCGA HNSC -0.068; TCGA KIRC -0.074; TCGA LGG -0.05; TCGA LUSC -0.123; TCGA PAAD -0.149; TCGA SARC -0.122; TCGA STAD -0.068 |
hsa-miR-340-5p | KLF8 | 9 cancers: BRCA; COAD; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.208; TCGA COAD -0.226; TCGA HNSC -0.2; TCGA LUSC -0.225; TCGA PAAD -0.175; TCGA PRAD -0.179; TCGA SARC -0.58; TCGA STAD -0.236; TCGA UCEC -0.266 |
hsa-miR-340-5p | TMEM106B | 9 cancers: BRCA; ESCA; KIRC; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.144; TCGA ESCA -0.202; TCGA KIRC -0.086; TCGA LGG -0.117; TCGA LUSC -0.093; TCGA PAAD -0.195; TCGA SARC -0.082; TCGA STAD -0.142; TCGA UCEC -0.124 |
hsa-miR-340-5p | SLAIN2 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.119; TCGA HNSC -0.087; TCGA KIRC -0.056; TCGA KIRP -0.066; TCGA LUSC -0.078; TCGA PAAD -0.168; TCGA SARC -0.163; TCGA STAD -0.143; TCGA UCEC -0.056 |
hsa-miR-340-5p | BBX | 9 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.215; TCGA COAD -0.097; TCGA KIRC -0.155; TCGA KIRP -0.214; TCGA LUSC -0.078; TCGA PAAD -0.16; TCGA SARC -0.205; TCGA STAD -0.106; TCGA UCEC -0.141 |
hsa-miR-340-5p | TANC1 | 9 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.176; TCGA COAD -0.073; TCGA KIRC -0.1; TCGA KIRP -0.216; TCGA LUSC -0.11; TCGA PAAD -0.204; TCGA SARC -0.412; TCGA STAD -0.226; TCGA UCEC -0.157 |
hsa-miR-340-5p | SGIP1 | 10 cancers: BRCA; CESC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.119; TCGA CESC -0.248; TCGA KIRC -0.17; TCGA KIRP -0.551; TCGA LUAD -0.109; TCGA LUSC -0.283; TCGA PAAD -0.22; TCGA SARC -0.758; TCGA STAD -0.182; TCGA UCEC -0.341 |
hsa-miR-340-5p | KDSR | 10 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUSC; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.205; TCGA CESC -0.08; TCGA HNSC -0.052; TCGA KIRP -0.08; TCGA LIHC -0.117; TCGA LUSC -0.127; TCGA PAAD -0.131; TCGA PRAD -0.051; TCGA SARC -0.107; TCGA UCEC -0.159 |
hsa-miR-340-5p | ZC3H13 | 9 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.243; TCGA COAD -0.166; TCGA ESCA -0.101; TCGA KIRC -0.115; TCGA KIRP -0.189; TCGA LUSC -0.069; TCGA PAAD -0.202; TCGA SARC -0.108; TCGA UCEC -0.125 |
hsa-miR-340-5p | FAM63B | 9 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.45; TCGA COAD -0.175; TCGA ESCA -0.171; TCGA KIRC -0.335; TCGA KIRP -0.576; TCGA LUSC -0.138; TCGA PAAD -0.388; TCGA SARC -0.475; TCGA UCEC -0.323 |
hsa-miR-340-5p | ARPP19 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.18; TCGA CESC -0.076; TCGA ESCA -0.171; TCGA HNSC -0.061; TCGA KIRC -0.06; TCGA KIRP -0.134; TCGA LUSC -0.094; TCGA PAAD -0.087; TCGA SARC -0.211; TCGA STAD -0.115; TCGA UCEC -0.079 |
hsa-miR-340-5p | LRCH2 | 9 cancers: BRCA; COAD; KIRC; KIRP; LGG; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.247; TCGA COAD -0.376; TCGA KIRC -0.212; TCGA KIRP -0.463; TCGA LGG -0.085; TCGA PRAD -0.387; TCGA SARC -0.307; TCGA STAD -0.323; TCGA UCEC -0.476 |
hsa-miR-340-5p | CLIP1 | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.167; TCGA COAD -0.114; TCGA ESCA -0.182; TCGA HNSC -0.154; TCGA KIRP -0.112; TCGA LUSC -0.171; TCGA PAAD -0.115; TCGA SARC -0.286; TCGA STAD -0.172; TCGA UCEC -0.138 |
hsa-miR-340-5p | VPS13B | 9 cancers: BRCA; ESCA; KIRP; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.156; TCGA ESCA -0.152; TCGA KIRP -0.199; TCGA LGG -0.058; TCGA LUSC -0.087; TCGA PAAD -0.147; TCGA SARC -0.176; TCGA STAD -0.109; TCGA UCEC -0.188 |
hsa-miR-340-5p | SERINC3 | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.221; TCGA COAD -0.108; TCGA ESCA -0.12; TCGA HNSC -0.072; TCGA KIRP -0.159; TCGA LUSC -0.13; TCGA PAAD -0.173; TCGA SARC -0.104; TCGA STAD -0.089; TCGA UCEC -0.148 |
hsa-miR-340-5p | ROCK2 | 9 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.395; TCGA COAD -0.164; TCGA ESCA -0.195; TCGA KIRC -0.143; TCGA KIRP -0.493; TCGA LUSC -0.122; TCGA PAAD -0.285; TCGA SARC -0.466; TCGA UCEC -0.294 |
hsa-miR-340-5p | KIF13A | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.333; TCGA ESCA -0.175; TCGA HNSC -0.118; TCGA KIRC -0.099; TCGA KIRP -0.269; TCGA LUSC -0.164; TCGA PAAD -0.21; TCGA SARC -0.26; TCGA STAD -0.162; TCGA UCEC -0.239 |
hsa-miR-340-5p | FGF7 | 9 cancers: BRCA; CESC; COAD; KIRC; KIRP; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.279; TCGA CESC -0.235; TCGA COAD -0.297; TCGA KIRC -0.369; TCGA KIRP -0.301; TCGA PAAD -0.378; TCGA PRAD -0.287; TCGA SARC -0.617; TCGA UCEC -0.653 |
hsa-miR-340-5p | PDGFC | 9 cancers: BRCA; CESC; COAD; LGG; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BRCA -0.315; TCGA CESC -0.219; TCGA COAD -0.317; TCGA LGG -0.088; TCGA LUSC -0.226; TCGA PAAD -0.651; TCGA PRAD -0.313; TCGA STAD -0.286; TCGA UCEC -0.2 |
hsa-miR-340-5p | TSLP | 9 cancers: BRCA; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.341; TCGA KIRC -0.272; TCGA KIRP -0.568; TCGA LGG -0.148; TCGA PAAD -0.356; TCGA PRAD -0.391; TCGA SARC -0.375; TCGA STAD -0.383; TCGA UCEC -0.196 |
hsa-miR-340-5p | EGFR | 9 cancers: BRCA; COAD; ESCA; KIRP; LGG; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.348; TCGA COAD -0.148; TCGA ESCA -0.501; TCGA KIRP -0.216; TCGA LGG -0.346; TCGA LUSC -0.387; TCGA PAAD -0.556; TCGA STAD -0.286; TCGA UCEC -0.391 |
hsa-miR-340-5p | ZNF827 | 10 cancers: BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.248; TCGA COAD -0.297; TCGA KIRC -0.184; TCGA KIRP -0.317; TCGA LUAD -0.077; TCGA LUSC -0.135; TCGA PAAD -0.23; TCGA SARC -0.296; TCGA STAD -0.223; TCGA UCEC -0.273 |
hsa-miR-340-5p | TAOK1 | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.486; TCGA COAD -0.182; TCGA ESCA -0.234; TCGA KIRC -0.216; TCGA KIRP -0.468; TCGA LUSC -0.157; TCGA PAAD -0.406; TCGA SARC -0.354; TCGA STAD -0.092; TCGA UCEC -0.176 |
hsa-miR-340-5p | CDC42EP3 | 10 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.161; TCGA COAD -0.171; TCGA KIRC -0.18; TCGA KIRP -0.359; TCGA LUSC -0.186; TCGA PAAD -0.142; TCGA PRAD -0.187; TCGA SARC -0.682; TCGA STAD -0.189; TCGA UCEC -0.356 |
hsa-miR-340-5p | TGFBR2 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.314; TCGA CESC -0.166; TCGA COAD -0.147; TCGA ESCA -0.224; TCGA KIRC -0.085; TCGA KIRP -0.285; TCGA LUSC -0.306; TCGA PAAD -0.227; TCGA STAD -0.142; TCGA UCEC -0.422 |
hsa-miR-340-5p | ZNF148 | 10 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.17; TCGA ESCA -0.137; TCGA KIRC -0.081; TCGA KIRP -0.148; TCGA LGG -0.07; TCGA LUSC -0.106; TCGA PAAD -0.167; TCGA SARC -0.138; TCGA STAD -0.076; TCGA UCEC -0.076 |
hsa-miR-340-5p | SGMS2 | 9 cancers: BRCA; CESC; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.229; TCGA CESC -0.154; TCGA HNSC -0.108; TCGA KIRP -0.279; TCGA LUSC -0.36; TCGA PAAD -0.493; TCGA SARC -0.422; TCGA STAD -0.298; TCGA UCEC -0.189 |
hsa-miR-340-5p | ITGA2 | 10 cancers: BRCA; ESCA; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.398; TCGA ESCA -0.243; TCGA KIRC -0.183; TCGA KIRP -0.601; TCGA LIHC -0.244; TCGA LUSC -0.311; TCGA PAAD -0.601; TCGA PRAD -0.195; TCGA SARC -0.245; TCGA UCEC -0.539 |
hsa-miR-340-5p | KIAA1161 | 10 cancers: BRCA; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.072; TCGA KIRC -0.364; TCGA KIRP -0.211; TCGA LUAD -0.147; TCGA LUSC -0.262; TCGA PAAD -0.247; TCGA PRAD -0.379; TCGA SARC -0.459; TCGA STAD -0.268; TCGA UCEC -0.202 |
hsa-miR-340-5p | REEP3 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BRCA -0.139; TCGA ESCA -0.252; TCGA HNSC -0.083; TCGA KIRC -0.066; TCGA KIRP -0.129; TCGA LUSC -0.215; TCGA PAAD -0.276; TCGA SARC -0.158; TCGA STAD -0.183 |
hsa-miR-340-5p | AMOTL1 | 9 cancers: BRCA; COAD; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.216; TCGA COAD -0.368; TCGA HNSC -0.097; TCGA KIRP -0.178; TCGA LUSC -0.249; TCGA PAAD -0.174; TCGA SARC -0.387; TCGA STAD -0.413; TCGA UCEC -0.317 |
hsa-miR-340-5p | PDE3A | 9 cancers: BRCA; KIRC; KIRP; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.483; TCGA KIRC -0.149; TCGA KIRP -0.597; TCGA LGG -0.193; TCGA LUSC -0.292; TCGA PAAD -0.455; TCGA SARC -0.91; TCGA STAD -0.439; TCGA UCEC -0.193 |
hsa-miR-340-5p | PAWR | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.162; TCGA ESCA -0.258; TCGA HNSC -0.146; TCGA KIRC -0.206; TCGA KIRP -0.264; TCGA LUSC -0.103; TCGA PAAD -0.233; TCGA SARC -0.812; TCGA UCEC -0.115 |
hsa-miR-340-5p | PAPPA | 9 cancers: BRCA; CESC; KIRC; LGG; LUSC; PAAD; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.286; TCGA CESC -0.276; TCGA KIRC -0.795; TCGA LGG -0.265; TCGA LUSC -0.529; TCGA PAAD -0.454; TCGA PRAD -0.236; TCGA SARC -0.36; TCGA UCEC -0.883 |
hsa-miR-340-5p | PRKG1 | 9 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.603; TCGA COAD -0.441; TCGA KIRC -0.193; TCGA KIRP -0.51; TCGA LUSC -0.385; TCGA PAAD -0.631; TCGA SARC -0.631; TCGA STAD -0.414; TCGA UCEC -0.657 |
hsa-miR-340-5p | TEAD1 | 10 cancers: BRCA; COAD; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.322; TCGA COAD -0.094; TCGA KIRC -0.105; TCGA KIRP -0.219; TCGA LGG -0.131; TCGA PAAD -0.19; TCGA PRAD -0.144; TCGA SARC -0.325; TCGA STAD -0.288; TCGA UCEC -0.189 |
hsa-miR-340-5p | MITF | 10 cancers: BRCA; CESC; COAD; KIRC; KIRP; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.253; TCGA CESC -0.181; TCGA COAD -0.337; TCGA KIRC -0.178; TCGA KIRP -0.13; TCGA PAAD -0.476; TCGA PRAD -0.154; TCGA SARC -0.417; TCGA STAD -0.277; TCGA UCEC -0.447 |
hsa-miR-340-5p | CHM | 9 cancers: BRCA; ESCA; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.227; TCGA ESCA -0.134; TCGA KIRC -0.098; TCGA KIRP -0.168; TCGA LUSC -0.078; TCGA PAAD -0.116; TCGA SARC -0.144; TCGA STAD -0.111; TCGA UCEC -0.142 |
hsa-miR-340-5p | NF1 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.254; TCGA ESCA -0.121; TCGA KIRC -0.08; TCGA KIRP -0.168; TCGA LGG -0.088; TCGA PAAD -0.179; TCGA SARC -0.292; TCGA STAD -0.101; TCGA UCEC -0.128 |
hsa-miR-340-5p | BMPR2 | 10 cancers: BRCA; COAD; KIRC; KIRP; LGG; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.227; TCGA COAD -0.112; TCGA KIRC -0.069; TCGA KIRP -0.245; TCGA LGG -0.069; TCGA LUSC -0.175; TCGA PAAD -0.175; TCGA SARC -0.176; TCGA STAD -0.113; TCGA UCEC -0.214 |
hsa-miR-340-5p | ATXN1L | 9 cancers: BRCA; COAD; KIRC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.233; TCGA COAD -0.105; TCGA KIRC -0.104; TCGA KIRP -0.118; TCGA LUSC -0.115; TCGA PAAD -0.18; TCGA SARC -0.095; TCGA STAD -0.126; TCGA UCEC -0.263 |
hsa-miR-340-5p | UTP14C | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; UCEC | mirMAP | TCGA BRCA -0.235; TCGA CESC -0.091; TCGA COAD -0.153; TCGA ESCA -0.12; TCGA KIRC -0.145; TCGA KIRP -0.162; TCGA LGG -0.061; TCGA LUSC -0.095; TCGA PAAD -0.175; TCGA UCEC -0.113 |
hsa-miR-340-5p | TSHZ3 | 11 cancers: BRCA; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.214; TCGA COAD -0.239; TCGA KIRC -0.086; TCGA KIRP -0.37; TCGA LUAD -0.087; TCGA LUSC -0.258; TCGA PAAD -0.163; TCGA PRAD -0.249; TCGA SARC -0.161; TCGA STAD -0.25; TCGA UCEC -0.536 |
hsa-miR-340-5p | ASAP2 | 9 cancers: BRCA; CESC; ESCA; KIRC; KIRP; PAAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.058; TCGA CESC -0.115; TCGA ESCA -0.23; TCGA KIRC -0.235; TCGA KIRP -0.454; TCGA PAAD -0.236; TCGA SARC -0.106; TCGA STAD -0.123; TCGA UCEC -0.109 |
hsa-miR-340-5p | UBR5 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; SARC | miRNATAP | TCGA BRCA -0.116; TCGA COAD -0.093; TCGA ESCA -0.149; TCGA HNSC -0.054; TCGA KIRC -0.089; TCGA KIRP -0.172; TCGA LUSC -0.079; TCGA PAAD -0.093; TCGA SARC -0.161 |
hsa-miR-340-5p | TES | 10 cancers: CESC; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.132; TCGA ESCA -0.182; TCGA HNSC -0.134; TCGA KIRP -0.166; TCGA LUSC -0.104; TCGA PAAD -0.264; TCGA PRAD -0.208; TCGA SARC -0.526; TCGA STAD -0.278; TCGA UCEC -0.15 |
hsa-miR-340-5p | MICAL2 | 9 cancers: CESC; COAD; ESCA; KIRP; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.198; TCGA COAD -0.128; TCGA ESCA -0.192; TCGA KIRP -0.223; TCGA LUSC -0.289; TCGA PAAD -0.285; TCGA SARC -0.351; TCGA STAD -0.268; TCGA UCEC -0.302 |
Enriched cancer pathways of putative targets